Series C - RenovoRx

Series C - RenovoRx

Investment Firm

Overview

RenovoRx is developing innovative solutions for targeted delivery of fluids to selected sites in the peripheral vascular system.

Announced Date

Dec 07, 2015

Closed on Date

Dec 07, 2015

Funding Type

Series C

Highlights

Location

United States, North America

Social

Investor Lead

N/A

Participant Investors

6

Investor Name
Participant InvestorThe Angels' Forum
Participant InvestorStartX (Stanford-StartX Fund)
Participant InvestorSand Hill Angels
Participant InvestorAstia Angels
Participant InvestorGolden Seeds

Round Details and Background

RenovoRx raised an undisclosed amount on 2015-12-07 in Series C

RenovoRx is developing innovative solutions for targeted delivery of fluids to selected sites in the peripheral vascular system.

Company Funding History

10

Announcment DateTransaction NameNumber Of InvestorsLead InvestorMoney Raised
Jan 24, 2013
Series A - RenovoRx
2-undefined
Dec 07, 2015
Series C - RenovoRx
7-undefined
Jan 28, 2014
Series B - RenovoRx
5-1.1M
Apr 10, 2013
Venture Round - RenovoRx
-660.0K

Recent Activity

There is no recent news or activity for this profile.